Business
Blocklisting - 6 Month Review
Blocklisting - 6 Month Review.
About this update from Hikma Pharmaceuticals Plc
[{"type":"text","content":"\n Hikma Pharmaceuticals Plc\n05 October 2007\n\n\n Block Listing - Six Monthly Review\n\nName of Company: Hikma Pharmaceuticals PLC\n\nName of scheme: Hikma Pharmaceuticals PLC 2004 Stock\n Option Plan\n\nPeriod of return: From: 6 April 2007 To: 5 October 2007\n\nBalance under block scheme: 1,719,400 ordinary shares of 10 pence\n each\n\nThe amount by which the block scheme has Nil\nbeen increased, if the scheme has been\nincreased since the date of the last\nreturn:\n\nNumber of securities issued/allotted 314,000 ordinary shares of 10 pence \nunder scheme during period: each\n\nBalance under scheme not yet issued/ 1,405,400 ordinary shares of 10 pence\nallotted at end of period each\n\nNumber and class of securities originally 166,537,951 ordinary shares of 10\nlisted and the date of admission pence each originally listed on 1 \n November 2005\n \nTotal number of securities in issue at 169,451,407 ordinary shares of 10 \nthe end of the period pence each\n\n\n - ENDS -\n\n\nEnquiries:\n\nHikma Pharmaceuticals PLC +44 20 7399 2760\nHenry Knowles, Company Secretary\nSusan Ringdal, Investor Relations Director\n\nNotes to Editors\n\n\nAbout Hikma\n\nHikma Pharmaceuticals PLC is a fast growing multinational group focused on\ndeveloping, manufacturing and marketing a broad range of both branded and\nnon-branded generic and in-licensed products. Hikma's operates through three\nbusinesses: 'Branded', 'Injectables' and 'Generics', based principally in the\nMiddle East and North Africa ('MENA'), where it is a market leader and sells\nacross 18 countries, the United States and Europe. In 2006, Hikma achieved\nrevenues of $317 million (2005 $262 million) and profit attributable to\nshareholders was $55 million (2005 $44 million). At 31 December 2006, the Group\nhad over 2,400 employees. For news and other information, please visit\nwww.hikma.com.\n\n\n\n\n This information is provided by RNS\n The company news service from the London Stock Exchange\n \n ","length":2568,"tagName":"div"}]